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Introduction
Congenital nephrogenic diabetes insipidus 
(NDI) is a rare disease caused by genetic 
mutations in AVPR2 or AQP2 (1). AVPR2 is 
located at the Xq28 locus, and it encodes arginine 
vasopressin receptor 2 (AVPR2). Mutations in 
AVPR2 have been associated with X-linked NDI. 
AQP2 is located at the 12q13.12 locus, and it 
encodes the water transporter aquaporin-2. 
Mutations in AQP2 result in autosomal NDI. 
Here, we describe a male infant with a novel 
AVPR2 variant who was referred to our hospital 
due to delayed head control.
Case Report
A 5-mo-old boy was referred to the 
Department of Child Neurology in Okayama 
University Hospital (Okayama, Japan) due 
to delayed head control. He was born to non-
consanguineous parents. His birth weight was 
3630 g (+ 1.39 SD) and birth length was 50.8 cm 
(+ 0.86 SD). He showed no signs of asphyxia. A 
recurrent fever of unknown origin was observed 
beginning at 2 mo of age. Poor weight gain was 
observed at 3 mo of age. Notably, he did not take 
any medications.
At his first visit to our hospital, the patient’s 
length was 62.6 cm (–1.55 SD) and weight was 
6190 g (–1.82 SD). His heart rate was 128 
bpm, and his body temperature was 36.8°C. 
He was dehydrated, and his head control was 
incomplete. Laboratory examination revealed 
that his sodium level and serum osmolarity 
were elevated, and his urinary osmolarity 
and specific gravity were noticeably low. Head 
magnetic resonance imaging scanning revealed 
that high posterior lobe intensity was absent 
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in T1-weighted images. However, the pituitary 
stalk was intact, and no other abnormalities 
were identified. These findings were indicative 
of diabetes insipidus. Water deprivation test 
with vasopressin challenge test resulted in no 
urine osmolarity increase and no urine volume 
decrease. Moreover, the AVP level at admission 
was extremely high (114 pg/mL; reference range; 
0.0–4.2 pg/mL). Based on these findings, we 
diagnosed the patient with congenital NDI. His 
urine volume decreased, his weight increased, 
and head control was achieved after initiation 
of hydrochlorothiazide.
Assessment of the patient’s family history 
revealed that his mother had polydipsia and 
polyuria from infancy until the present day 
(Fig. 1A). She also had increased levels of 
sodium of unknown origin during each of her 
three pregnancies. Furthermore, the patient’s 
maternal grandfather, maternal great-
grandfather, and maternal aunt had histories 
of polyuria and polydipsia. We suspected that our 
patient had familial NDI and, thus, conducted 
a genetic analysis.
Mutational Analysis
Genetic analysis was approved by the 
ethical committee of Okayama University 
Hospital and conducted in accordance with the 
1975 Declaration of Helsinki and subsequent 
amendments. Informed consent for genetic 
analysis was obtained from the patient’s mother.
We identified a hemizygous four-base pair 
duplication in exon 3 of AVPR2 (c.990_993 dup 
CAGC, Fig. 1B). This four-base pair duplication 
results in early termination (p.Val332Gln 
Fs26X). This variant was previously unreported, 
and it is not present in the 1000 Genomes Project 
databases (http://www.internationalgenome.
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Fig. 1. A: Family tree of our patient (arrow). Black square and black circle indicate family members with 
polydipsia and polyuria, respectively. Arrow indicates our patient. B: Results of mutation analysis. 
Our patient showed hemizygous duplication of four base pairs (c.990_993 dup CAGC; single bold line 
indicates CAGC). His older brother did not show this duplication. His mother was heterozygous for 
the wild-type allele and the four-base pair duplication (dotted line).
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org/1000-genomes-browers), the Human Genetic 
Variation Database (http://www.hgvd.genome.
med.kyoto-u.ac.jp), or the Exome Aggregation 
Consortium Server (http://exac.broadinstitute.
org). This variant is considered to be likely 
pathogenic based on ACMG criteria (PS1, PM2 
and PM4). We suspected that the patient’s mother 
was heterozygous for the wild-type allele and the 
four-base pair duplication. Thus, an amplicon 
obtained from the mother was cloned into a PCR® 
4-TOPO® vector using the TOPO® TA Cloning® 
Kit for Sequencing (Thermo Fisher Scientific, 
Waltham, MA, USA), and each transformant was, 
subsequently, sequenced. The results confirmed 
heterozygosity for the wild-type allele and the 
four-base pair duplication. Since the patient’s 
mother suspected that the patient’s older brother 
had polydipsia, we also analyzed the patient’s 
older brother, However, the patient’s brother 
did not carry the four-base pair duplication. 
Notably, we did not analyze AQP2 in our patient, 
and we did not perform genetic analysis for his 
father, older sister, maternal aunt, maternal 
grandfather, or maternal great-grandfather.
Discussion
We identified a novel AVPR2 variant in a 
patient with familial congenital NDI. Duplication 
variants are relatively rare among X-linked NDI 
patients: insertion AVPR2 variants were found 
in only about 5% of large cohort (1) and Japanese 
patients (2).
There are five classes of loss of function 
mutations in AVPR2 (1). Class I mutations 
result in unstable mRNA, which undergoes 
nonsense-mediated RNA decay. Class II 
mutations cause misfolding of receptors, 
and these mutant receptors remain in the 
endoplasmic reticulum. Class III mutations also 
cause receptor misfolding. Class III receptors 
reach the plasma membrane and react with AVP, 
but subsequent interactions with G proteins 
and cAMP production are impaired. Class IV 
mutations also result in misfolded receptors 
that reach the plasma membrane, but result in 
incomplete AVP binding. Class V mutations cause 
mis-sorting to incorrect cellular compartments. 
A duplication of four bases in exon 3 of AVPR2 
causes early termination. However, this is the 
final exon, which might avoid nonsense-mediated 
RNA decay (3). Residue 332 is located in an 
intracellular domain that does not bind to AVP. 
Therefore, the variant in our patient may lose its 
function via a non-class I mechanism. Functional 
analysis is needed to clarify the pathophysiology 
of this variant.
Congenital NDI is generally identified by 
the presence of DI symptoms like polyuria, 
polydipsia, fever, and poor weight gain (2). 
The patient whose case is reported here was 
referred to the department of Child Neurology 
in our hospital because of delayed head control, 
poor weight gain, and fever. After treating his 
dehydration, he gained head control and his 
development proceeded normally. We consider 
delayed motor development in infancy to be an 
important clinical symptom of congenital NDI.
The patient’s mother had a heterozygous 
AVPR2 variant. She demonstrated a high sodium 
level during each of her pregnancies, but her 
sodium levels were normal before pregnancy 
and after birth for all children. In gestational 
DI, urinary volume increases during pregnancy 
because of increased clearance of AVP by placental 
vasopressinase, a cystine aminopeptidase that 
strongly degrades AVP (4). Although inactivation 
of the X chromosome was not analyzed in the 
patient’s mother, AVP resistance and degradation 
by vasopressinase, might have contributed to her 
high sodium levels during pregnancy.
In conclusion, we identified a novel AVPR2 
variant in a patient with familial congenital 
NDI. Common symptoms of DI were observed, 
including polyuria, polydipsia, poor weight gain, 
and fever, and delayed motor development was 
also observed during infancy.
Conflict of Interest: The authors declare 




We thank the patient and his family for 
participating in this study.
References
 1. Moeller HB, Rittig S, Fenton RA. Nephrogenic 
diabetes insipidus: essential insights into the 
molecular background and potential therapies 
for treatment. Endocr Rev 2013;34: 278–301. 
[Medline]  [CrossRef]
 2. Fujimoto M, Okada S, Kawashima Y, Nishimura 
R, Miyahara N, Kawaba Y, et al. Clinical 
overview of nephrogenic diabetes insipidus based 
on a nationwide survey in Japan. Yonago Acta 
Med 2014;57: 85–91. [Medline]
 3. Holbrook JA, Neu-Yilik G, Hentze MW, Kulozik 
AE. Nonsense-mediated decay approaches the 
clinic. Nat Genet 2004;36: 801–8. [Medline] 
[CrossRef]
 4. Ananthakrishnan S. Diabetes insipidus during 
pregnancy. Best Pract Res Clin Endocrinol 
Metab 2016;30: 305–15. [Medline]  [CrossRef]
Vol.28 / No.4
